306 related articles for article (PubMed ID: 8706016)
1. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells.
Shimizu M; Yamamoto A; Nakano H; Matsuzawa A
Cancer Res; 1996 Aug; 56(16):3731-6. PubMed ID: 8706016
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
Lussow AR; MacDonald HR
Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
[TBL] [Abstract][Full Text] [Related]
4. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
Miethke T; Wahl C; Heeg K; Wagner H
J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
[TBL] [Abstract][Full Text] [Related]
5. Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin-2 pathway.
Gonzalo JA; Moreno de Alborán I; Alés-Martínez JE; Martínez C; Kroemer G
Eur J Immunol; 1992 Apr; 22(4):1007-11. PubMed ID: 1551401
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of staphylococcal enterotoxin B upon the induction of tolerance on peripheral CD4+V beta 8+ and CD8+V beta 8+ T cells.
Sabapathy TK; Hwang LA; Hui KM
Cell Immunol; 1994 Oct; 158(1):83-95. PubMed ID: 7916268
[TBL] [Abstract][Full Text] [Related]
7. In vivo tumor immunotherapy by a bacterial superantigen.
Ochi A; Migita K; Xu J; Siminovitch K
J Immunol; 1993 Sep; 151(6):3180-6. PubMed ID: 8376773
[TBL] [Abstract][Full Text] [Related]
8. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
[TBL] [Abstract][Full Text] [Related]
9. Superantigen-induced anergy of V beta 8+ CD4+ T cells induces functional but non-proliferative T cells in vivo.
Gaus H; Miethke T; Wagner H; Heeg K
Immunology; 1994 Nov; 83(3):333-40. PubMed ID: 7835956
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of peripheral T cell deletion: anergized T cells are Fas resistant but undergo proliferation-associated apoptosis.
Miethke T; Vabulas R; Bittlingmaier R; Heeg K; Wagner H
Eur J Immunol; 1996 Jul; 26(7):1459-67. PubMed ID: 8766547
[TBL] [Abstract][Full Text] [Related]
12. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
13. Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor. Activation-induced cell death vs passive macrophage-dependent deletion.
Gonzalo JA; Baixeras E; González-García A; George-Chandy A; Van Rooijen N; Martínez C; Kroemer G
J Immunol; 1994 Feb; 152(4):1597-608. PubMed ID: 8120373
[TBL] [Abstract][Full Text] [Related]
14. Clonal anergy to staphylococcal enterotoxin B in vivo: selective effects on T cell subsets and lymphokines.
Baschieri S; Lees RK; Lussow AR; MacDonald HR
Eur J Immunol; 1993 Oct; 23(10):2661-6. PubMed ID: 8104798
[TBL] [Abstract][Full Text] [Related]
15. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice.
Scott DE; Kisch WJ; Steinberg AD
J Immunol; 1993 Jan; 150(2):664-72. PubMed ID: 8419493
[TBL] [Abstract][Full Text] [Related]
16. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
Wen R; Blackman MA; Woodland DL
J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcal enterotoxin B induces arthritis in female DBA/1 mice but fails to induce activation of type II collagen-reactive lymphocytes.
Omata S; Sasaki T; Kakimoto K; Yamashita U
Cell Immunol; 1997 Aug; 179(2):138-45. PubMed ID: 9268497
[TBL] [Abstract][Full Text] [Related]
18. Pertussis toxin interferes with superantigen-induced deletion of peripheral T cells without affecting T cell activation in vivo. Inhibition of deletion and associated programmed cell death depends on ADP-ribosyltransferase activity.
Gonzalo JA; González-García A; Baixeras E; Zamzami N; Tarazona R; Rappuoli R; Martínez C; Kroemer G; Tarazona R; Terezone R
J Immunol; 1994 May; 152(9):4291-9. PubMed ID: 7908917
[TBL] [Abstract][Full Text] [Related]
19. Administration of recombinant human IL-1 by Staphylococcus enterotoxin B prevents tolerance induction in vivo.
Nakata Y; Matsuda K; Uzawa A; Nomura M; Akashi M; Suzuki G
J Immunol; 1995 Nov; 155(9):4231-5. PubMed ID: 7594579
[TBL] [Abstract][Full Text] [Related]
20. Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells.
Okamoto S; Kawabata S; Nakagawa I; Hamada S
Infect Immun; 2001 Nov; 69(11):6633-42. PubMed ID: 11598032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
